SCTX Scribe Therapeutics, Inc.: institutional ownership and insider trading
2 funds reported holding $61.0K of Scribe Therapeutics, Inc. in their latest 13F filings; over the last 12 months insiders bought $71.3M and sold $0 on the open market.
Largest institutional holders of SCTX
- TEMA ETFS LLC — $56.1K
- Sterling Capital Management LLC — $4.95K
Recent SCTX insider trades
- Jul 28, 2026: Avoro Capital Advisors LLC bought 2,391,238 shares ($36.3M)
- Jul 27, 2026: Andreessen Marc L bought 333,333 shares ($5.00M)
- Jul 27, 2026: Gordon Carl L bought 1,000,000 shares ($15.0M)
- Jul 27, 2026: Orbimed Advisors Llc bought 1,000,000 shares ($15.0M)
5%+ owners
- Aghazadeh Behzad: 16.4% (Schedule 13D, filed Jul 30, 2026)
- RA Capital Management, L.P.: 9.6% (Schedule 13G, filed Aug 3, 2026)
- ELI LILLY & Co: 7.3% (Schedule 13D, filed Jul 30, 2026)
- ORBIMED ADVISORS LLC: 7.2% (Schedule 13D, filed Jul 29, 2026)